Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

EXPLAINED: Enfusion s return on invested capital insights - The Real Truth

According to data from Benzinga Pro, during Q1, Enfusion's (NYSE:ENFN) reported sales totaled $34.14 million. Despite a 95.74% increase in earnings, the company posted a loss of $12.52 million. In Q4, Enfusion brought in $31.85 million in sales but lost $293.89 million in earnings.

Why Is ROIC Significant?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.